Provider of cardiac treatments intended to be used for treating acute decompensated heart failure. The company's cardiac treatments address the condition's root cause of reduced contractility using neuromodulation to increase contractility, thus improving cardiac output and increasing renal flow or end-organ perfusion, enabling healthcare practitioners to decrease negative hormonal signaling and improve in-hospital morbidity and mortality.